<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Am Chem Soc</journal-id><journal-id journal-id-type="iso-abbrev">J. Am. Chem. Soc</journal-id><journal-id journal-id-type="publisher-id">ja</journal-id><journal-id journal-id-type="coden">jacsat</journal-id><journal-title-group><journal-title>Journal of the American Chemical Society</journal-title></journal-title-group><issn pub-type="ppub">0002-7863</issn><issn pub-type="epub">1520-5126</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5269645</article-id><article-id pub-id-type="doi">10.1021/jacs.6b10075</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Contribution
of Shape and Charge to the Inhibition
of a Family GH99 <italic>endo</italic>-&#x003b1;-1,2-Mannanase</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Petricevic</surname><given-names>Marija</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Sobala</surname><given-names>Lukasz F.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Fernandes</surname><given-names>Pearl Z.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Raich</surname><given-names>Llu&#x000ed;s</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Thompson</surname><given-names>Andrew J.</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Bernardo-Seisdedos</surname><given-names>Ganeko</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Millet</surname><given-names>Oscar</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath8"><name><surname>Zhu</surname><given-names>Sha</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath9"><name><surname>Sollogoub</surname><given-names>Matthieu</given-names></name><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath10"><name><surname>Jim&#x000e9;nez-Barbero</surname><given-names>Jes&#x000fa;s</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref><xref rid="aff7" ref-type="aff">&#x02207;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath11"><name><surname>Rovira</surname><given-names>Carme</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff5" ref-type="aff">&#x022a5;</xref><xref rid="aff6" ref-type="aff">#</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath12"><name><surname>Davies</surname><given-names>Gideon J.</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath13"><name><surname>Williams</surname><given-names>Spencer J.</given-names></name><xref rid="cor3" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>School
of Chemistry and Bio21 Molecular Science and Biotechnology Institute, <institution>University of Melbourne</institution>, Parkville 3010, <country>Australia</country></aff><aff id="aff2"><label>&#x02021;</label>York
Structural Biology Laboratory, Department of Chemistry, <institution>University of York</institution>, York YO10 5DD, <country>United
Kingdom</country></aff><aff id="aff3"><label>&#x000a7;</label>Sorbonne Universit&#x000e9;s,
UPMC Univ Paris 06, CNRS, Institut Parisien de Chimie Mol&#x000e9;culaire
(IPCM), UMR 8232, 4, place Jussieu, 75005 Paris, <country>France</country></aff><aff id="aff4"><label>&#x02225;</label>Molecular
Recognition
and Host&#x02212;Pathogen Interactions, CIC bioGUNE, Bizkaia Technology Park, Building 800, 48160 Derio, <country>Spain</country></aff><aff id="aff5"><label>&#x022a5;</label>Departament
de Qu&#x000ed;mica Inorg&#x000e0;nica i Org&#x000e0;nica (Secci&#x000f3;
de Qu&#x000ed;mica Org&#x000e0;nica) &#x00026; Institut de Qu&#x000ed;mica
Te&#x000f2;rica i Computacional (IQTCUB), <institution>Universitat de Barcelona</institution>, Mart&#x000ed; i Franqu&#x000e8;s 1, 08028 Barcelona, <country>Spain</country></aff><aff id="aff6"><label>#</label><institution>Instituci&#x000f3;
Catalana de Recerca i Estudis Avan&#x000e7;ats (ICREA)</institution>, Pg. Llu&#x000ed;s Companys 23, 08010 Barcelona, <country>Spain</country></aff><aff id="aff7"><label>&#x02207;</label>Ikerbasque, Basque
Foundation for Science, Mar&#x000ed;a
D&#x000ed;az de Haro 3, 48013 Bilbao, <country>Spain</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label><email>c.rovira@ub.edu</email></corresp><corresp id="cor2"><label>*</label><email>gideon.davies@york.ac.uk</email></corresp><corresp id="cor3"><label>*</label><email>sjwill@unimelb.edu.au</email></corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>12</month><year>2016</year></pub-date><pub-date pub-type="ppub"><day>25</day><month>01</month><year>2017</year></pub-date><volume>139</volume><issue>3</issue><fpage>1089</fpage><lpage>1097</lpage><history><date date-type="received"><day>25</day><month>09</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 American Chemical Society</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0008" id="ab-tgr1"/></p><p>Inhibitor
design incorporating features of the reaction coordinate
and transition-state structure has emerged as a powerful approach
for the development of enzyme inhibitors. Such inhibitors find use
as mechanistic probes, chemical biology tools, and therapeutics. <italic>Endo</italic>-&#x003b1;-1,2-mannosidases and <italic>endo</italic>-&#x003b1;-1,2-mannanases,
members of glycoside hydrolase family 99 (GH99), are interesting targets
for inhibitor development as they play key roles in N-glycan maturation
and microbiotal yeast mannan degradation, respectively. These enzymes
are proposed to act via a 1,2-anhydrosugar &#x0201c;epoxide&#x0201d;
mechanism that proceeds through an unusual conformational itinerary.
Here, we explore how shape and charge contribute to binding of diverse
inhibitors of these enzymes. We report the synthesis of neutral dideoxy,
glucal and cyclohexenyl disaccharide inhibitors, their binding to
GH99 <italic>endo</italic>-&#x003b1;-1,2-mannanases, and their structural
analysis by X-ray crystallography. Quantum mechanical calculations
of the free energy landscapes reveal how the neutral inhibitors provide
shape but not charge mimicry of the proposed intermediate and transition
state structures. Building upon the knowledge of shape and charge
contributions to inhibition of family GH99 enzymes, we design and
synthesize &#x003b1;-Man-1,3-noeuromycin, which is revealed to be the
most potent inhibitor (<italic>K</italic><sub>D</sub> 13 nM for <italic>Bacteroides xylanisolvens</italic> GH99 enzyme) of these enzymes
yet reported. This work reveals how shape and charge mimicry of transition
state features can enable the rational design of potent inhibitors.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ja6b10075</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ja-2016-10075v</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>Introduction</title><p>Over
500&#x0202f;000 gene sequences have been discovered encoding
glycoside hydrolases that are grouped into more than 130 families
according to the Carbohydrate Active enZyme classification (CAZy: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.cazy.org">www.cazy.org</uri>).<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Glycoside hydrolases of family 99 possess two distinct
activities: <italic>endo</italic>-&#x003b1;-1,2-mannosidase and <italic>endo</italic>-&#x003b1;-1,2-mannanase. <italic>endo</italic>-&#x003b1;-1,2-Mannosidases
are eukaryotic proteins involved in N-linked glycan maturation, folding,
and quality control<sup><xref ref-type="bibr" rid="ref2">2</xref>&#x02212;<xref ref-type="bibr" rid="ref5">5</xref></sup> and are of clinical significance as they provide a means for viruses
and cancer to evade the effect of <italic>exo</italic>-glucosidase
inhibitors.<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref></sup><italic>endo</italic>-&#x003b1;-1,2-Mannanases
are produced by <italic>Bacteroides</italic> spp., bacterial residents
of the gut microbiota.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> They facilitate
the degradation of dietary yeast mannan consumed in bread and fermented
foods, facilitating the breakdown of these complex carbohydrates,
with beneficial effects on the gastrointestinal tract and, possibly,
mitigating the symptoms of Crohn&#x02019;s disease.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> Given the importance of family GH99 enzymes in N-linked
glycan maturation and carbohydrate processing by the microbiota, the
development of inhibitors has been of particular importance to allow
assessment and manipulation of their roles in these complex processes.
In this work, we investigate several mechanism-inspired inhibitor
design concepts for family GH99 <italic>endo</italic>-&#x003b1;-1,2-mannanases
from the gut microbiota constituents <italic>Bacteroides thetaiotaomicron</italic> and <italic>Bacteroides xylanisolvens</italic>; <italic>BtGH99</italic> and <italic>BxGH99</italic>, respectively. Our results cast light
on the importance of structural mimicry of shape and charge of species
along the reaction coordinate for achieving potent inhibition of this
enzyme family.</p><p>Glycosidases that cleave their substrates with
retention of anomeric
configuration typically operate through a two-step mechanism that
proceeds via a covalent glycosyl-enzyme intermediate. Such enzymes
utilize enzymatic amino acid residues that in the first step act as
general acid and nucleophile to assist in departure of the anomeric
substituent while simultaneously substituting the anomeric group;
in the second step the first carboxylate acts as a general base to
deprotonate a nucleophilic water molecule that hydrolyzes the covalent
glycosyl enzyme intermediate (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>A).<sup><xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref></sup> Important exceptions include
a range of &#x003b2;-hexosaminidases that perform catalysis through
mechanisms involving neighboring group participation by the 2-acetamido
group of the substrate (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>B).<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> These enzymes also operate
through a two-step mechanism: in the first step an amino acid residue
acts as a general acid to assist in departure of the leaving group
while the 2-acetamido group performs a nucleophilic attack on the
anomeric center, forming a bicyclic oxazoline/oxazolinium ion intermediate.
In the second step the same amino acid residue acts as a general base,
assisting nucleophilic attack by a water molecule that opens the oxazolinium
ion ring, reforming the 2-acetamido group and completing the hydrolysis
reaction.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(A) Mechanism for a canonical retaining &#x003b1;-glycosidase that
proceeds through a covalent glycosyl-enzyme intermediate. (B) Mechanism
for a retaining &#x003b2;-hexosaminidase involving neighboring group
participation by the 2-acetamido group, via an oxazolinium ion intermediate.
(C) Proposed mechanism for family GH99 &#x003b1;-mannosidases involving
neighboring group participation by the 2-OH group, via a 1,2-anhydro
sugar (epoxide). Numbering is for <italic>Bx</italic>GH99.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0001" id="gr3" position="float"/></fig><p>Family GH99 enzymes cleave glycosides with an overall
retention
of anomeric configuration.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> X-ray structures
are available for GH99 enzymes in complex with a variety of ligands
based on sugar-shaped heterocycles.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> However, in X-ray structures of <italic>B. xylanisolvens
Bx</italic>GH99 with various substrate-mimicking ligands, it was not
possible to identify an appropriately positioned enzymatic nucleophile
within the typical &#x0003c;3 &#x000c5; distance from the reactive anomeric
center, leading to the proposal of a nonclassical mechanism.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> In particular, in structures of GlcIFG (<bold>2</bold>) and ManIFG (<bold>3</bold>) with <italic>Bx</italic>GH99,
there were no close contacts with a likely candidate enzymatic nucleophile,<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> at odds with the usual observation of a carboxylate situated typically
2.6&#x02013;2.7 &#x000c5; away in classical retaining glycosidases. Moreover,
in complexes of GlcDMJ (<bold>1</bold>) with <italic>Bx</italic>GH99
a conserved carboxyl residue (E333; numbering refers to <italic>Bx</italic>GH99) was located 2.7 &#x000c5; from the 2-OH group;<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> similar observations extend to the binding of a substrate
(&#x003b1;-Man-1,3-&#x003b1;-ManMU) to the carboxamide mutant <italic>Bx</italic>GH99 E333Q.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Collectively these
data supported the proposal of a two-step reaction involving in the
first step the formation of a bicyclic 1,2-anhydro sugar intermediate,
through E333 acting as a general base residue to deprotonate the 2-OH
and facilitating a nucleophilic substitution at C1 coincident with
departure of the leaving group, assisted by E336 acting as general
acid (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>C).<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> In the second step of this proposed mechanism,
E333 acts as a general acid, assisting ring opening of the epoxide,
while E336 acts as a general base, promoting nucleophilic attack by
a water molecule. While such a mechanism lacks precedent in enzymes,
there is strong evidence that the base-catalyzed solvolysis of 4-nitrophenyl
&#x003b1;-<sc>d</sc>-mannoside and &#x003b1;-mannosyl fluoride proceed
through similar neighboring group participation mechanisms.<sup><xref ref-type="bibr" rid="ref13">13</xref>&#x02212;<xref ref-type="bibr" rid="ref16">16</xref></sup> The most stable conformation of 1,2-anhydro-&#x003b2;-<sc>d</sc>-mannose
is a <sup>4</sup><italic>H</italic><sub>5</sub> half-chair; applying
the principle of least nuclear motion, a <sup>4</sup><italic>C</italic><sub>1</sub> &#x02192; <sup>4</sup><italic>E</italic><sup>&#x02021;</sup> &#x02192; <sup>4</sup><italic>H</italic><sub>5</sub> conformational
itinerary has been proposed for the first step of the family GH99
reaction coordinate.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup></p><p>Intensive
efforts have been invested in the rational development
of glycosidase inhibitors, and many fundamental principles have been
articulated inspired by our deep mechanistic understanding of this
class of enzyme. Based on pioneering insights from Pauling<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> and Wolfenden,<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> it
is recognized that a common principle underpinning catalysis is the
selective affinity of an enzyme for a reaction transition state, relative
to the ground state. Accordingly, inhibitor design by transition state
mimicry, which can take advantage of the high transition state affinity
of a glycosidase, has proven a useful guiding strategy.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> While it is widely appreciated that perfect
transition state mimics are chemically unstable and thus unattainable,
a general design principle is to develop analogues incorporating features
that mimic the shape and charge of the transition state.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> Three features have been highlighted for consideration
in the development of effective glycosidase inhibitors: configuration,
conformation and charge.<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> Configuration
is the simplest to address and not surprisingly it is usually found
that glycosidases are normally best targeted by inhibitors with stereochemistry
matching that of the substrate. In the case of <italic>Bx</italic>GH99, an enzyme that has the ability to cleave both &#x003b1;-Glc-1,3-&#x003b1;-Man-OR
and &#x003b1;-Man-1,3-&#x003b1;-Man-OR configured substrates (with a preference
for the latter),<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> optimal inhibition is
achieved by inhibitors matching the preferred substrate configuration.
Glycosidases typically operate through transition states with substantial
oxocarbenium ion character, and partial double bond development between
O5 and C1, leading to a flattened conformation at the transition state.
Consequently, mimicry of the flattened conformation expected at the
transition state has proven a second effective strategy, with inhibitors
bearing sp<sup>2</sup>-hybridized atoms at the anomeric or endocyclic
oxygen positions, such as glyconolactones and -lactams, identified
as fairly broad spectrum glycosidase inhibitors. Finally, partial
charge development at C1 and the endocyclic oxygen at the transition
state can be mimicked by the protonated forms of nitrogen-containing
heterocycles, exemplified by deoxymannojirimycin (DMJ) with a nitrogen
in place of the endocyclic oxygen, and isofagomine with a nitrogen
in place of C1.</p><p>Motivated by the unusual mechanism proposed
for family GH99 enzymes
and the complexity of their biochemical roles, our understanding of
which should benefit from the development of potent inhibitors, we
undertook a study of several inhibitor designs inspired by the concepts
of charge and shape mimicry. GlcDMJ (<bold>1</bold>), an inhibitor
reported by Spiro and co-workers,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> was
the first effective inhibitor of mammalian <italic>endo</italic>-&#x003b1;-1,2-mannosidase,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and was subsequently shown to bind to and inhibit <italic>Bx</italic>GH99 and <italic>Bt</italic>GH99 (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> More potent
inhibition was achieved by GlcIFG (<bold>2</bold>),<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> which also proved to be a more effective inhibitor than
GlcDMJ of mammalian <italic>endo</italic>-&#x003b1;-1,2-mannosidase
in cell-based studies,<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> demonstrating
that varying the position of charge can provide improvements in potency.
Further, upon identification of the <italic>Bacteroides</italic> spp.
enzymes as preferential <italic>endo</italic>-&#x003b1;-1,2-mannanases,<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup> we were able to configurationally match the substrate and develop
the inhibitor ManIFG (<bold>3</bold>), the most potent inhibitor yet
reported for any GH99 enzyme.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> However,
ManIFG and GlcIFG lack the 2-OH group of the substrate and thus cannot
benefit from specific interactions with the putative acid/base E333.
Separately, Spiro and co-workers reported that two other neutral compounds
were almost as effective as GlcDMJ in the inhibition of mammalian <italic>endo</italic>-&#x003b1;-1,2-mannosidase, namely, GlcddMan (<bold>4</bold>) and GlcGlucal (<bold>6</bold>).<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> We were intrigued
by these observations and sought to investigate whether the equivalent
configurationally matched species, ManddMan (<bold>5</bold>) and ManGlucal
(<bold>7</bold>), and the related cyclohexene derivative (<bold>8</bold>) were inhibitors of bacterial GH99 enzymes and to understand how
they bind to the enzyme.<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0009" id="fx1" position="float"/></p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Dissociation Constants
for GH99 <italic>endo</italic>-Mannanase Inhibitors</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th colspan="2" align="center"><italic>K</italic><sub>D</sub> values (&#x003bc;M)<hr/></th><th style="border:none;" align="center">&#x000a0;</th></tr><tr><th style="border:none;" align="center">compd</th><th style="border:none;" align="center"><italic>Bt</italic>GH99</th><th style="border:none;" align="center"><italic>Bx</italic>GH99</th><th style="border:none;" align="center">method</th></tr></thead><tbody><tr><td style="border:none;" align="left"><bold>1</bold>&#x000a0;(GlcDMJ)</td><td style="border:none;" align="left">24</td><td style="border:none;" align="left">ND<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">ITC<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></td></tr><tr><td style="border:none;" align="left"><bold>2</bold>&#x000a0;(GlcIFG)</td><td style="border:none;" align="left">0.63</td><td style="border:none;" align="left">ND<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">ITC<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></td></tr><tr><td style="border:none;" align="left"><bold>3</bold>&#x000a0;(ManIFG)</td><td style="border:none;" align="left">0.14</td><td style="border:none;" align="left">0.27</td><td style="border:none;" align="left">ITC<sup><xref ref-type="bibr" rid="ref6">6</xref></sup></td></tr><tr><td style="border:none;" align="left"><bold>5</bold>&#x000a0;(ManddMan)</td><td style="border:none;" align="left">53&#x000a0;&#x000b1;&#x000a0;5</td><td style="border:none;" align="left">221&#x000a0;&#x000b1;&#x000a0;11</td><td style="border:none;" align="left">NMR</td></tr><tr><td style="border:none;" align="left"><bold>7</bold>&#x000a0;(ManGlucal)</td><td style="border:none;" align="left">15&#x000a0;&#x000b1;&#x000a0;1.9</td><td style="border:none;" align="left">111&#x000a0;&#x000b1;&#x000a0;11</td><td style="border:none;" align="left">NMR</td></tr><tr><td style="border:none;" align="left"><bold>8</bold>&#x000a0;(GlcChex)</td><td style="border:none;" align="left">no&#x000a0;binding</td><td style="border:none;" align="left">no&#x000a0;binding</td><td style="border:none;" align="left">NMR/ITC</td></tr><tr><td style="border:none;" align="left"><bold>9</bold>&#x000a0;(ManNOE)</td><td style="border:none;" align="left">0.03&#x000a0;&#x000b1;&#x000a0;0.01</td><td style="border:none;" align="left">0.013&#x000a0;&#x000b1;&#x000a0;0.002</td><td style="border:none;" align="left">ITC</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>ND, not determined.</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2"><title>Results and Discussion</title><sec id="sec2.1"><title>Synthesis of ManGlucal
and ManddMan</title><p>ManddMan (<bold>5</bold>) and ManGlucal (<bold>7</bold>) were prepared from &#x003b1;-1,3-mannobiose
(<bold>10</bold>) (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). Acetylation, followed by bromination afforded mannobiosyl
bromide (<bold>12</bold>), which was converted to the protected glucal
(<bold>13</bold>) using Zn in MeOH. Zempl&#x000e9;n transesterification
afforded ManGlucal (<bold>7</bold>). Alternatively, reduction of <bold>13</bold> using H<sub>2</sub>/Pd&#x02013;C, followed by Zempl&#x000e9;n
transesterification afforded ManddMan (<bold>5</bold>). The preparation
of GlcChex (<bold>8</bold>) will be described elsewhere.</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Synthesis
of ManddMan (<bold>5</bold>) and ManGlucal (<bold>7</bold>)</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0006" id="gr1" position="float"/></fig></sec><sec id="sec2.2"><title>Binding and 3-D Structural
Analyses of Putative &#x0201c;Shape
Mimics&#x0201d;</title><p>Dissociation constants for the binding of
compounds <bold>5</bold> and <bold>7</bold> to <italic>Bt</italic>GH99 and <italic>Bx</italic>GH99 were determined by NMR spectroscopy
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">Figure S1</ext-link>). The 2D NMR SOFAST-HMQC spectra
of <sup>15</sup>N-labeled enzymes determined in the presence or absence
of a saturating amount of the ligands revealed several H&#x02013;N
peaks that displayed significant chemical shift perturbations. For
instance, new signals for an arginine residue (assigned as R295 in <italic>Bx</italic>GH99 and R291 in <italic>Bt</italic>GH99 on the basis
of analysis of inter-residue nOes from the 3D-HSQC-NOESY spectra;
see annotation to <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A) appeared during the titration experiments, which were in
slow exchange with the initial ones in the chemical shift time scale
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Therefore,
since the relative intensities of these signals are proportional to
the populations of the bound and unbound forms (see <xref rid="sec4" ref-type="other">Experimental Section</xref> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">Supporting Information</ext-link> (SI)), the dissociation constants (<italic>K</italic><sub>D</sub>) were readily calculated. The binding constants are shown in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. No evidence for
binding of GlcChex could be obtained by either NMR or ITC.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Excerpt of
the side chain HN &#x003b5;-arginine region in the 2D
SOFAST-HMQC NMR spectra of <sup>15</sup>N-labeled <italic>Bt</italic>GH99 in the absence (blue) or presence of an excess (top) of ManGlucal
(<bold>7</bold>; red) or (bottom) ManddMan (<bold>5</bold>; green).
The arrow highlights the chemical shift perturbation observed for
the HN-&#x003b5; signal corresponding to R295.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0002" id="gr4" position="float"/></fig><p>In order to analyze the mode of binding of the conformationally
restricted compounds, 3-D structures of complexes of <italic>Bx</italic>GH99 with <bold>7</bold> and <bold>8</bold> were determined by X-ray
crystallography at near atomic (approximately 1.0 &#x000c5;) resolutions
(<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>, <xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A,B). ManGlucal <bold>7</bold> (<italic>K</italic><sub>D</sub> 111 &#x003bc;M) binds to <italic>Bx</italic>GH99 in the &#x02212;2 and &#x02212;1 subsites, with the
&#x02212;1 glucal ring intact in a <sup>4</sup><italic>H</italic><sub>5</sub> conformation. For reasons most likely related to its poor
affinity for the enzyme, we were unable to obtain a complex of GlcChex
with wildtype enzyme, but were serendipitously successful in obtaining
a complex with the catalytically inactive <italic>Bx</italic>GH99
E333Q mutant. In this complex GlcChex <bold>8</bold> also bound in
the &#x02212;2/&#x02013;1 subsite with the cyclohexene ring in a <sup>4</sup><italic>H</italic><sub>5</sub> conformation (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>B). Relative to ManGlucal,
GlcChex suffers both by replacement of the endocyclic oxygen with
methylene and by the presence of a nonreducing-end glucosyl moiety,
the latter of which is known to reduce binding to the <italic>Bacteroides</italic> spp. enzymes by 4&#x02013;10-fold.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Owing
to the unmeasurable binding of GlcChex, the synthesis of the mannose
analogue was not pursued. The lack of oxygen atoms within the GlcChex
ring means it cannot form hydrogen bonds with active site residues
Y252, E333 or E336. MS experiments indicated that the compound is
not affected by the enzyme or its variants so the reason for binding
to only the inactive variant is unclear.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Stereoview of active
site of <italic>B. xylanisolvens</italic> family
GH99 enzyme complexes. (A) <italic>Bx</italic>GH99 with ManGlucal
(<bold>7</bold>), (B) <italic>Bx</italic>GH99-E333Q with GlcChex (<bold>8</bold>), and (C) <italic>Bx</italic>GH99 with ManddMan (<bold>5</bold>). Depicted electron density maps are REFMAC<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> maximum-likelihood/&#x003c3;A weighted 2<italic>F</italic><sub>0</sub> &#x02013; <italic>F</italic><sub>c</sub> syntheses contoured at 1.5&#x003c3;
(0.57, 0.59, and 0.62 <italic>e</italic>&#x000c5;<sup>&#x02013;3</sup>, respectively). All panels were assembled using CCP4mg.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0003" id="gr5" position="float"/></fig><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>X-ray Data and Structure Summary</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center"><bold>5</bold>&#x000a0;(ManddMan)</th><th style="border:none;" align="center"><bold>7</bold>&#x000a0;(ManGlucal)</th><th style="border:none;" align="center"><bold>8</bold>&#x000a0;(GlcChex)</th><th style="border:none;" align="center"><bold>10</bold>&#x000a0;(ManNOE)</th><th style="border:none;" align="center"><bold>10</bold>&#x000a0;+&#x000a0;M<sub>2</sub> (ManNOE&#x000a0;+&#x000a0;1,2-&#x003b1;-mannobiose)</th></tr></thead><tbody><tr><td style="border:none;" align="left">resolution (outer shell)
(&#x000c5;)</td><td style="border:none;" align="left">76.77&#x02013;1.03 (1.05&#x02013;1.03)</td><td style="border:none;" align="left">76.85&#x02013;1.07 (1.09&#x02013;1.07)</td><td style="border:none;" align="left">39.54&#x02013;1.2 (1.22&#x02013;1.2)</td><td style="border:none;" align="left">76.73&#x02013;1.14 (1.16&#x02013;1.14)</td><td style="border:none;" align="left">57.21&#x02013;1.05 (1.07&#x02013;1.05)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>merge</sub> (outer)</td><td style="border:none;" align="left">0.052&#x000a0;(0.989)</td><td style="border:none;" align="left">0.052&#x000a0;(1.748)</td><td style="border:none;" align="left">0.059&#x000a0;(0.955)</td><td style="border:none;" align="left">0.051&#x000a0;(1.158)</td><td style="border:none;" align="left">0.054&#x000a0;(1.314)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>cryst</sub>/<italic>R</italic><sub>free</sub></td><td style="border:none;" align="left">0.117/0.130</td><td style="border:none;" align="left">0.124/0.141</td><td style="border:none;" align="left">0.119/0.137</td><td style="border:none;" align="left">0.124/0.143</td><td style="border:none;" align="left">0.115/0.133</td></tr><tr><td style="border:none;" align="left">rmsd bonds (&#x000c5;)</td><td style="border:none;" align="left">0.010</td><td style="border:none;" align="left">0.011</td><td style="border:none;" align="left">0.012</td><td style="border:none;" align="left">0.011</td><td style="border:none;" align="left">0.013</td></tr><tr><td style="border:none;" align="left">rmsd angles (deg)</td><td style="border:none;" align="left">1.53</td><td style="border:none;" align="left">1.54</td><td style="border:none;" align="left">1.59</td><td style="border:none;" align="left">1.50</td><td style="border:none;" align="left">1.67</td></tr><tr><td style="border:none;" align="left">PDB code</td><td style="border:none;" align="left">5M17</td><td style="border:none;" align="left">5M5D</td><td style="border:none;" align="left">5MEL</td><td style="border:none;" align="left">5LYR</td><td style="border:none;" align="left">5M03</td></tr></tbody></table></table-wrap><p>Glycals are often effective inhibitors of classical
retaining glycosidases.
Inhibition is typically found to be time-dependent, owing to a chemical
reaction in which the conjugate acid of the nucleophile protonates
the enol ether of the glycal, and forms a 2-deoxy-glycosyl enzyme.<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> This mode of reactivity has been exploited to allow the identification
of the catalytic nucleophile by peptide sequencing,<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> and the 2-deoxyglycosyl-enzymes are sufficiently stable
to be studied by X-ray crystallography.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> To date, only two classes of retaining glycosidases have been identified
upon which glycals bind as competitive inhibitors without exhibiting
this mode of reactivity. These are <italic>N</italic>-acetylhexosaminidases
that use neighboring group participation and retaining sialidases,
and in both cases these enzymes lack a typical carboxylate nucleophile.
Retaining <italic>N</italic>-acetylhexosaminidases use a 2-acetamido
group, which is able to catalyze the slow hydration of the enol ether.<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> Retaining sialidases lack a carboxylate nucleophile
capable of protonating the glycal, and instead use a less acidic tyrosine
residue as the catalytic nucleophile.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> In the case of sialidases, the corresponding glycal 2,3-didehydro-2-deoxy-<italic>N</italic>-acetylneuraminic acid has been elaborated into the extraordinarily
potent inhibitor zanamivir,<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> a clinically
used antiinfluenza drug. Despite its potency, quantitative examination
of transition state mimicry by zanamivir reveals it to be a poor transition
state mimic.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> The observation that ManGlucal
binds to <italic>Bx</italic>GH99 without a chemical reaction despite
the retaining mechanism of the enzyme provides further evidence in
favor of the unique neighboring group participation mechanism proposed
for this family.</p></sec><sec id="sec2.3"><title>Binding and 3-D Structural Analyses of ManddMan:
Probing the
Role of O2 Interactions</title><p>In order to harness the tighter binding
of the bacterial enzymes with a mannoside in the &#x02212;2 subsite<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> ManddMan (<bold>5</bold>) was synthesized (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). NMR titration
revealed ManddMan to bind to <italic>Bx</italic>GH99 and <italic>Bt</italic>GH99 with <italic>K</italic><sub>D</sub> values of 221 and 53 &#x003bc;M,
respectively (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). By comparison, GlcddMan (<bold>4</bold>) is an inhibitor for rat
endomannosidase<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> with an IC<sub>50</sub> value of 3.8 &#x003bc;M for inhibition of cleavage of <sup>14</sup>C-labeled GlcMan<sub>9</sub>GlcNAc, only slightly worse than that
of GlcDMJ (<bold>1</bold>) (IC<sub>50</sub> = 1.7 &#x003bc;M). The structure
of <italic>Bx</italic>GH99 in complex with ManddMan was determined
at 1.03 &#x000c5; resolution. Compound <bold>5</bold> binds in the &#x02212;2/&#x02013;1
subsites of the enzyme in an undistorted <sup>4</sup><italic>C</italic><sub>1</sub> conformation. This conformation matches that of the
ground state of the substrate, and while this is consistent with the
modest dissociation constant, it is noteworthy that the tight-binding
inhibitor ManIFG <bold>3</bold> also binds in a <sup>4</sup><italic>C</italic><sub>1</sub> chair.</p></sec><sec id="sec2.4"><title>Design, Synthesis, and
Characterization of ManNOE as a GH99
Inhibitor</title><p>As ManIFG (<bold>3</bold>), ManddMan (<bold>5</bold>), and ManGlucal (<bold>7</bold>) all lack an O2 group, in considering
the contribution of shape and charge to inhibition, it would appear
that the cationic nature of ManIFG contributes most significantly
to inhibition, in spite of its conformational resemblance to the ground
state. We therefore decided that it would be appropriate to investigate
a charged inhibitor based on ManIFG that was able to make the correct
O2 interactions, in particular with E333. Inspired by the work of
Bols and co-workers on the development of noeuromycin, a 2-hydroxy
analogue of isofagomine that binds 2&#x02013;4000 times more tightly
than isofagomine to various glycosidases,<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> we therefore synthesized the noeuromycin derivative, ManNOE. This
inhibitor was synthesized by the regioselective mannosylation of the
nitrile diol <bold>16</bold>(<xref ref-type="bibr" rid="ref35">35</xref>) by trichloroacetimidate <bold>15</bold><xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> The sole acetate group of the glycoside <bold>17</bold> was cleaved by treatment with HCl/MeOH to afford alcohol <bold>18</bold>, and the nitrile group was reduced using BH<sub>3</sub>&#x000b7;Me<sub>2</sub>S, followed by protection as the Boc derivative <bold>19</bold>. Hydrogenolysis of the benzyl ethers of <bold>19</bold> using H<sub>2</sub>/Pd&#x02013;C, and then cleavage of the Boc group
with HCl, afforded ManNOE.HCl (<bold>9</bold>) [as a mixture of &#x003b1;-hydroxypiperidine
and pyranose isomers (not drawn); see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">SI</ext-link>].</p><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Synthesis of ManNOE (<bold>9</bold>)</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0007" id="gr2" position="float"/></fig><p>Isothermal titration calorimetry revealed ManNOE (<bold>9</bold>) to bind to <italic>Bx</italic>GH99 with <italic>K</italic><sub>D</sub> = 13 nM, and to <italic>Bt</italic>GH99 with a <italic>K</italic><sub>D</sub> = 30 nM, 17- and 5-fold more tightly than
ManIFG (<bold>3</bold>) to the respective enzymes, commensurate with
improvements
seen for binding of IFG versus NOE for other enzymes,<sup><xref ref-type="bibr" rid="ref34">34</xref>,<xref ref-type="bibr" rid="ref37">37</xref></sup> and demonstrating that better matching of the substrate by reinstatement
of the 2-OH group absent in the latter compound provides more effective
inhibition (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">Figure S4</ext-link>). 3-D structures were solved
of a binary complex of <italic>Bx</italic>GH99&#x02013;ManNOE, and
a ternary complex of <italic>Bx</italic>GH99&#x02013;ManNOE&#x02212;&#x003b1;-1,2-mannobiose
at resolutions of 1.14 and 1.05 &#x000c5;, respectively (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>). The poses of ManNOE in both complexes were essentially
identical and the more informative ternary complex, with ManNOE in
the &#x02212;2/&#x02013;1 subsites, and &#x003b1;-1,2-mannobiose in the
+1/+2 subsites will therefore be discussed. The NOE heterocycle binds
in a <sup>4</sup><italic>C</italic><sub>1</sub> conformation, similar
to that seen for ManIFG with the same enzyme. A close contact with
E333 O&#x003b4;&#x000b7;&#x000b7;&#x000b7;O2 of 2.58 &#x000c5; is evident, similar
to that seen in the complex of <italic>Bx</italic>GH99 with GlcDMJ
(2.54 &#x000c5;, PDB 4AD3).</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>(A) X-ray structure of ternary complex of <italic>Bx</italic>GH99
with ManNOE (above) and &#x003b1;-1,2-mannobiose (below). The residue
used for NMR titrations, R295, is shown in yellow. 2<italic>F</italic><sub>0</sub> &#x02013; <italic>F</italic><sub>c</sub> map contoured
at 1.0 &#x003c3; (0.42 <italic>e</italic>&#x000c5;<sup>&#x02013;3</sup>).
The +1 subsite mannose residue electron density is best modeled by
two mannose conformations with 0.6/0.4 occupancy, rotated by about
30&#x000b0; with respect to +2 mannose. (B) Stereoview of ManNOE in the
active site. 2<italic>F</italic><sub>0</sub> &#x02013; <italic>F</italic><sub>c</sub> map contoured at 1.5 &#x003c3; (0.58 <italic>e</italic>&#x000c5;<sup>&#x02013;3</sup>). Assembled using CCP4mg.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0004" id="gr6" position="float"/></fig></sec><sec id="sec2.5"><title>Conformational Analyses
of Glucal, Chex, ddMan, and NOE</title><p>In order to understand the
intrinsic conformational preferences of
the D-glucal, 1,2-dideoxymannose (ddMan), Chex, and noeuromycin (NOE)
inhibitor warheads, so as to help rationalize the conformations observed
on-enzyme, we calculated their conformational free energy landscapes
(FELs). FELs were computed by ab initio metadynamics (see <xref rid="sec4" ref-type="other">Experimental Section</xref>), and the Cremer&#x02013;Pople
puckering coordinates &#x003b8; and &#x003d5; were used as collective
variables, yielding a Mercator representation<sup><xref ref-type="bibr" rid="ref38">38</xref></sup> for each inhibitor FEL (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>). The same procedure has been previously used to analyze
the conformational preferences of related GH inhibitors (mannoimidazole,
glucoimidazole, and IFG).<sup><xref ref-type="bibr" rid="ref39">39</xref>,<xref ref-type="bibr" rid="ref40">40</xref></sup></p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Conformational free-energy
landscapes (FELs, Mercator projection)
of isolated D-glucal (A), Chex (B), ddMan (C), and NOE (D), contoured
at 1 kcal mol<sup>&#x02013;1</sup>. FELs have been annotated (yellow
star) with the inhibitor conformations of ManGlucal <bold>7</bold> (for A), GlcChex <bold>8</bold> (for B), ManddMan <bold>5</bold> (for C), and ManNOE <bold>9</bold> (for D) that have been observed
on-enzyme in this work.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_0005" id="gr7" position="float"/></fig><p>The FELs of both D-glucal and Chex (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A,B) exhibit a main energy minimum centered
at <sup>4</sup><italic>H</italic><sub>5</sub>. The free energy well
is quite large and extends through <sup>4</sup><italic>E</italic>&#x02013;<sup>4</sup><italic>H</italic><sub>5</sub>&#x02013;<italic>E</italic><sub>5</sub>, with an &#x0201c;arm&#x0201d; toward <italic>B</italic><sub>3,O</sub>, indicating substantial conformational freedom around <sup>4</sup><italic>H</italic><sub>5</sub>. There is also a local minimum
in the southern hemisphere, centered at <sup>5</sup><italic>H</italic><sub>4</sub>. However, this is 3 kcal mol<sup>&#x02013;1</sup> higher
in energy and thus less populated at room temperature. Interconversion
between the two minima is hindered by an 8 kcal mol<sup>&#x02013;1</sup> energy barrier. Therefore, both D-glucal and Chex display only one
main accessible conformation at room temperature, <sup>4</sup><italic>H</italic><sub>5</sub>, but can readily adopt the nearby <sup>4</sup><italic>E</italic> conformation predicted for the transition states
leading to and from the proposed 1,2-anhydrosugar intermediate. These
data suggest that D-glucal and Chex provide good shape mimicry of
the transition state or intermediate for the GH99 catalyzed reaction.</p><p>That both D-glucal and Chex adopt a <sup>4</sup><italic>H</italic><sub>5</sub> conformation when complexed to <italic>Bx</italic>GH99
(<xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> and yellow
star in <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A,B)
indicates that the conformational preference of the isolated molecules
are not significantly perturbed on-enzyme. This is also the case for
ddMan, for which the FEL (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>C) is strongly biased toward the <sup>4</sup><italic>C</italic><sub>1</sub> chair (the local minima on the equator are
&#x02248;8 kcal/mol higher in energy), as observed in the X-ray structure
on-enzyme. However, the FEL of ddMan does not exhibit any stable minimum
around <sup>4</sup><italic>H</italic><sub>5</sub>, thus it cannot
be considered a GH99 transition state shape mimic, and should instead
be considered a mimic of the substrate conformation in the Michaelis
complex.</p><p>NOE differs from the other inhibitors considered here
as it is
a basic molecule and was therefore considered as both the neutral
(<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>D) and protonated
species (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">Figure S5</ext-link>). While the topographies
of the FELs for the two protonation states are broadly similar, they
differ greatly in relative energies, most importantly for the global
and local minima, such that the most stable state in NOE, a <sup>4</sup><italic>C</italic><sub>1</sub> chair, becomes the &#x0201c;ring-flipped&#x0201d; <sup>1</sup><italic>C</italic><sub>4</sub> conformer in protonated NOE.
In that case, the two most stable species, the <sup>1</sup><italic>C</italic><sub>4</sub> and <sup>1</sup><italic>S</italic><sub>5</sub> states, are characterized by the presence of transannular hydrogen
bonds between NH<sub>2</sub><sup>+</sup> and O6 or O3, respectively.
What then is the most appropriate FEL to consider in relation to the
enzyme-bound state, which is expected to be protonated, but which
in a <sup>4</sup><italic>C</italic><sub>1</sub> conformation lacks
a transannular hydrogen bond? It is known that in the absence of solvation
(in the gas phase) flexible molecules in low charge states tend to
compensate charge effects by forming stabilizing intramolecular interactions
that do not take place in other environments (e.g., in solution).
For example, low-charge state proteins in the gas phase tend to adopt
more compact structures owing to increased intramolecular interactions.<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> On balance, we consider the FEL of neutral NOE
to be a more relevant representation of the enzyme-bound conformations,
because interactions of the inhibitor with active site residues prevent
the formation of intramolecular hydrogen bonds that dominate the conformations
of charged species. Accordingly, the FEL displays a wide main minimum
situated close to <sup>4</sup><italic>C</italic><sub>1</sub> (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>D), and is thus similar
to that of ddMan. The NOE FEL is also reminiscent of the one previously
computed for the closely related neutral IFG inhibitor<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> (which differs from NOE by the absence of the
2-hydroxyl group). Interestingly, the transition state region between
the north pole and the equator in NOE (<sup>4</sup><italic>H</italic><sub>3</sub>/<sup>4</sup><italic>E</italic>) is shifted by 60&#x000b0;
in &#x003d5; in ddMan. This is likely due to a vicinal intramolecular
hydrogen bond formed between the 2-OH and the 3-OH, which stabilizes
the <sup>4</sup><italic>H</italic><sub>3</sub>/<sup>4</sup><italic>E</italic> conformations in NOE; this interaction is not present
in ddMan or IFG as they both lack a 2-OH. Overall, NOE most closely
resembles the conformation of the substrate in the Michaelis complex
and in its protonated state on-enzyme provides mimicry of an oxocarbenium-ion-like
transition state; it is therefore best considered a &#x0201c;charge&#x0201d;-mimicking
inhibitor with no significant shape mimicry of the transition state.</p></sec></sec><sec id="sec3"><title>Conclusions</title><p>The proposed GH family 99 neighboring group
participation mechanism,
via a 1,2-anhydro sugar, allows prediction of a <sup>4</sup><italic>C</italic><sub>1</sub> &#x02192; <sup>4</sup><italic>E</italic><sup>&#x02021;</sup> &#x02192; <sup>4</sup><italic>H</italic><sub>5</sub> conformational itinerary for the first step of the reaction coordinate.
The FELs for Glucal and Chex suggest that when these inhibitor warheads
are extended to ManGlucal and GlcChex, their flattened conformations
provide mimicry of the <sup>4</sup><italic>E</italic> transition state
and <sup>4</sup><italic>H</italic><sub>5</sub> intermediate conformations.
Their nonbasic nature provides shape but not charge mimicry of the
transition state. X-ray structures of these compounds in complex with <italic>Bx</italic>GH99 revealed them to bind in a <sup>4</sup><italic>H</italic><sub>5</sub> conformation, most closely matching the proposed intermediate
conformation. The modest dissociation constant of ManGlucal, and lack
of detectable binding for GlcChex, suggests that shape mimicry of
the intermediate or transition state provides only weak affinity for
the enzyme. On the other hand the FEL for the neutral sugar ddMan
reveals a preference for a <sup>4</sup><italic>C</italic><sub>1</sub> conformation, and the corresponding complex of ManddMan with <italic>Bx</italic>GH99 revealed this compound to bind in the same conformation,
albeit with an affinity relative to ManGlucal 8- or 18-fold worse
for <italic>Bx</italic> or <italic>Bt</italic>GH99 enzymes, respectively.
As ManGlucal, GlcChex and ManddMan all lack a 2-OH group, these ratios
provide an estimate for the contribution of shape-mimicry of the TS
or intermediate to enzyme binding.</p><p>Based on the above analysis,
and combined with the previous discovery
that the best inhibitor for GH99 <italic>endo</italic>-&#x003b1;-mannanases
is ManIFG,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> which provides charge mimicry,
but poor transition state shape mimicry, we were inspired to reinstate
the 2-hydroxyl group missing in this compound. ManNOE was synthesized
and shown to bind to <italic>Bx</italic> and <italic>Bt</italic>GH99
with <italic>K</italic><sub>D</sub> values of 30 and 13 nM, the most
tightly binding ligand for these enzymes yet reported, and a 20-fold
enhancement of affinity relative to ManIFG. The X-ray structure of
ManNOE in complex with BxGH99 reveals a <sup>4</sup><italic>C</italic><sub>1</sub> ground-state conformation mimicking the Michaelis complex,
and we conclude that this inhibitor acts primarily to mimic the charge
of the transition state.</p></sec><sec id="sec4"><title>Experimental Section</title><sec id="sec4.1"><title>X-ray
Crystallography</title><p>Data reduction was performed
using xia2<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> or XDS.<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> Data set HKL index was matched to a previous solution using
Aimless<sup><xref ref-type="bibr" rid="ref44">44</xref>,<xref ref-type="bibr" rid="ref45">45</xref></sup> software and FreeR set was generated from <italic>Bx</italic>GH99&#x02013;ManddMan data, and then used for every other
data set. Initial polypeptide chain model was obtained from the same
previous solution, refined against <italic>Bx</italic>GH99&#x02013;ManddMan
data and used as starting model for other structure solutions. Refmac5<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> with ProSmart was used for restrained refinement
and Coot<sup><xref ref-type="bibr" rid="ref46">46</xref></sup> for real-space refinement. During
model rebuilding the <italic>F</italic><sub>obs</sub> &#x02013; <italic>F</italic><sub>calc</sub> difference map was examined at 3&#x003c3;.
Validation was performed using Coot and edstats.<sup><xref ref-type="bibr" rid="ref47">47</xref></sup> Sugar and pseudopyranose conformations and density correlation
were validated by Privateer.<sup><xref ref-type="bibr" rid="ref48">48</xref>,<xref ref-type="bibr" rid="ref49">49</xref></sup></p></sec><sec id="sec4.2"><title>Isothermal Titration Calorimetry</title><p>ManNOE binding to <italic>Bt</italic> and <italic>Bx</italic>GH99
was measured using a MicroCal
AutoITC200 instrument (Malvern Instruments, formerly GE Healthcare)
at 25 &#x000b0;C in 25 mM HEPES pH 7.0, 100 mM NaCl buffer. Protein concentration
was kept at 5 &#x003bc;M and ligand concentration at 50 &#x003bc;M. As
ManNOE exists as a 5:2 ratio of <sc>d</sc>-gluco and <sc>d</sc>-manno
NOE isomers; the effective ManNOE concentration was adjusted accordingly.</p></sec><sec id="sec4.3"><title>2D NMR Titrations</title><p>Two-dimensional <sup>1</sup>H&#x02013;<sup>15</sup>N SOFAST-HMQC<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> spectra were recorded
at 298 K for 1 h using <sup>15</sup>N-labeled <italic>Bt</italic>GH99
and <italic>Bx</italic>GH99 on a Bruker AVANCE III 800 MHz spectrometer
with cryoprobe. Upon binding of ManGlucal or ManddMan, chemical shift
perturbations were observed in slow exchange regime. A signal corresponding
to N&#x003b5;-H&#x003b5; of R295 (numbering based on <italic>Bx</italic>GH99), and which is close to the enzyme active site, was chosen as
binding reporter. In the case of <italic>Bx</italic>GH99, this signal
shifts from &#x003b4; 7.33, 87.5 ppm (<sup>1</sup>H,<sup>15</sup>N)
in the free state to &#x003b4; 7.41, 87.2 ppm (<sup>1</sup>H,<sup>15</sup>N) in the bound state. Bound and free protein populations at different
protein/ligand ratios were calculated from peak intensities. NMR measurements
were made in 50 mM potassium phosphate pH 7.0, 50 mM KCl with 5% D<sub>2</sub>O added. Protein concentration was determined by measuring
280 nm UV absorbance after denaturing the solution in 6 M guanidinium
chloride (average protein concentration: 58 &#x003bc;M). Ligand concentrations
were cross verified by integrating the <sup>1</sup>H peaks against
the internal standard TSP-<italic>d</italic><sub>4</sub> (Sigma-Aldrich).
The NMR data were processed and integrated using NMRPipe.<sup><xref ref-type="bibr" rid="ref51">51</xref></sup> The dissociation constants (<italic>K</italic><sub>D</sub> values) were estimated using in-house Matlab 2015b scripts,
using the following equation:<disp-formula id="ueq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja-2016-10075v_m001" position="anchor"/></disp-formula>where L is the
free ligand concentration and
([PL]/P<sub>T</sub>) is the ligand-bound protein fraction. Duplicate
experimental points were used for error-bar estimation. Errors were
propagated using a Monte Carlo algorithm to estimate the uncertainty
in the <italic>K</italic><sub>D</sub> values. A distribution of <italic>K</italic><sub>D</sub> values (<italic>n</italic> = 10&#x0202f;000)
were obtained from data sets randomly varying within the error bars,
and the standard deviation of was used for the <italic>K</italic><sub>D</sub> error estimation.</p></sec><sec id="sec4.4"><title>Quantum Chemical Calculations</title><p>To
obtain the conformational
free energy landscapes of ddMan, Glucal, Chex, and NOE, quantum mechanical
calculations were performed using density functional theory based
molecular dynamics (MD), according to the Car&#x02013;Parrinello (CP)
method.<sup><xref ref-type="bibr" rid="ref52">52</xref></sup> Each molecule was enclosed in
an isolated cubic box of 12.0 &#x000c5; &#x000d7; 12.0 &#x000c5; &#x000d7; 12.0
&#x000c5;. A fictitious electron mass of 700 au was used for the CP Lagrangian
and a time step of 0.12 fs was used in all CPMD simulations. The Kohn&#x02013;Sham
orbitals were expanded in a plane wave (PW) basis set with a kinetic
energy cutoff of 70 Ry. Ab initio pseudopotentials, generated within
the Troullier&#x02013;Martins scheme, were employed.<sup><xref ref-type="bibr" rid="ref53">53</xref></sup> The Perdew, Burke, and Ernzerhoff generalized gradient-corrected
approximation (PBE)<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> was selected in view
of its good performance in previous work on isolated sugars,<sup><xref ref-type="bibr" rid="ref55">55</xref></sup> glycosidases,<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> and
glycosyltransferases.<sup><xref ref-type="bibr" rid="ref57">57</xref></sup></p><p>The metadynamics
algorithm,<sup><xref ref-type="bibr" rid="ref58">58</xref></sup> provided by the Plumed 2 plugin,<sup><xref ref-type="bibr" rid="ref59">59</xref></sup> was used to explore the conformational free
energy landscape of the systems, taking as collective variables &#x003b8;
and &#x003c6; of the puckering coordinates of Cremer and Pople,<sup><xref ref-type="bibr" rid="ref60">60</xref></sup> in the spirit of the pioneering work by Dowd,
French, and Reilly.<sup><xref ref-type="bibr" rid="ref61">61</xref></sup> Initially, the height
of these Gaussian terms was set at 0.6 kcal mol<sup>&#x02013;1</sup> and a new Gaussian-like potential was added every 250 MD steps.
Once the whole free energy space was explored, the height of the Gaussian
terms was reduced to half of its initial value (0.3 kcal&#x000b7;mol<sup>&#x02013;1</sup>) and a new Gaussian-like potential was added every
500 MD steps. The width of the Gaussian terms was set to 0.10 &#x000c5;.
The simulations were stopped when energy differences among wells remain
constant, which was further confirmed by a time-independent free energy
estimator.<sup><xref ref-type="bibr" rid="ref62">62</xref></sup> For all molecules, the phase
space was fully explored in less than 60 ps and the simulations were
further extended up to 140 ps for Chex and Glucal, 160 ps for ddMan,
and 240 ps for NOE. The errors in the principal minima, taken as a
standard deviation (SD) from the last 60 ps, are below 0.6 kcal mol<sup>&#x02013;1</sup> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">Figure S6</ext-link>).</p></sec></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p>The Supporting
Information
is available free of charge on the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org">ACS Publications website</ext-link> at DOI: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/abs/10.1021/jacs.6b10075">10.1021/jacs.6b10075</ext-link>.<list id="silist" list-type="simple"><list-item><p>Experimental procedures,
analytical data (<sup>1</sup>H and <sup>13</sup>C NMR, MS) for all
new compounds; detailed crystallographic
experimental and data (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/jacs.6b10075/suppl_file/ja6b10075_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ja6b10075_si_001.pdf"><caption><p>ja6b10075_si_001.pdf</p></caption></media></supplementary-material></sec><notes id="notes-3" notes-type="COI-statement"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We thank
the Australian Research Council (FT130100103; DP120101396),
the BBSRC (BB/G016127/1) and the ERC (ERC-2012-AdG-322942), the Spanish
Ministry of Economy and Competitiveness (CTQ2014-55174, CTQ2015-64597-C2-1P,
CTQ2015-68756-R) and the Generalitat de Catalunya (2014SGR-987). We
thank Diamond Light Source for access to beamlines i02, i04, i04-1,
and i24 (mx-9948) that contributed to the results presented here.
We are grateful to Sivanandam Veeramuthu for his help with NMR. In-house
crystal screening and testing was performed on X-ray equipment provided,
in part, by the Wellcome Trust. The authors gratefully acknowledge
the computer resources at <italic>MareNostrum</italic> and the technical
support provided by BSC-CNS (RES-QCM-2016-3-00017). L.R. thanks the
University of Barcelona for an APIF predoctoral fellowship.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Lombard</surname><given-names>V.</given-names></name>; <name><surname>Golaconda Ramulu</surname><given-names>H.</given-names></name>; <name><surname>Drula</surname><given-names>E.</given-names></name>; <name><surname>Coutinho</surname><given-names>P. M.</given-names></name>; <name><surname>Henrissat</surname><given-names>B.</given-names></name>
<source>Nucleic Acids Res.</source>
<year>2014</year>, <volume>42</volume>, <fpage>D490</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1178</pub-id>.<pub-id pub-id-type="pmid">24270786</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Lubas</surname><given-names>W. A.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1987</year>, <volume>262</volume>, <fpage>3775</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">3818665</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Lubas</surname><given-names>W. A.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1988</year>, <volume>263</volume>, <fpage>3990</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">3346233</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Moore</surname><given-names>S. E.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1990</year>, <volume>265</volume>, <fpage>13104</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">2165493</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Moore</surname><given-names>S. E.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1992</year>, <volume>267</volume>, <fpage>8443</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">1533222</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Hiraizumi</surname><given-names>S.</given-names></name>; <name><surname>Spohr</surname><given-names>U.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>J. Biol. Chem.</source>
<year>1993</year>, <volume>268</volume>, <fpage>9927</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">8486671</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Hakki</surname><given-names>Z.</given-names></name>; <name><surname>Thompson</surname><given-names>A. J.</given-names></name>; <name><surname>Bellmaine</surname><given-names>S.</given-names></name>; <name><surname>Speciale</surname><given-names>G.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>
<source>Chem. - Eur. J.</source>
<year>2015</year>, <volume>21</volume>, <fpage>1966</fpage>&#x02013;<lpage>77</lpage><pub-id pub-id-type="doi">10.1002/chem.201405539</pub-id>.<pub-id pub-id-type="pmid">25487964</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Cuskin</surname><given-names>F.</given-names></name>; <name><surname>Lowe</surname><given-names>E. C.</given-names></name>; <name><surname>Temple</surname><given-names>M. J.</given-names></name>; <name><surname>Zhu</surname><given-names>Y.</given-names></name>; <name><surname>Cameron</surname><given-names>E. A.</given-names></name>; <name><surname>Pudlo</surname><given-names>N. A.</given-names></name>; <name><surname>Porter</surname><given-names>N. T.</given-names></name>; <name><surname>Urs</surname><given-names>K.</given-names></name>; <name><surname>Thompson</surname><given-names>A. J.</given-names></name>; <name><surname>Cartmell</surname><given-names>A.</given-names></name>; <name><surname>Rogowski</surname><given-names>A.</given-names></name>; <name><surname>Hamilton</surname><given-names>B. S.</given-names></name>; <name><surname>Chen</surname><given-names>R.</given-names></name>; <name><surname>Tolbert</surname><given-names>T. J.</given-names></name>; <name><surname>Piens</surname><given-names>K.</given-names></name>; <name><surname>Bracke</surname><given-names>D.</given-names></name>; <name><surname>Vervecken</surname><given-names>W.</given-names></name>; <name><surname>Hakki</surname><given-names>Z.</given-names></name>; <name><surname>Speciale</surname><given-names>G.</given-names></name>; <name><surname>Munoz-Munoz</surname><given-names>J. L.</given-names></name>; <name><surname>Day</surname><given-names>A.</given-names></name>; <name><surname>Pena</surname><given-names>M. J.</given-names></name>; <name><surname>McLean</surname><given-names>R.</given-names></name>; <name><surname>Suits</surname><given-names>M. D.</given-names></name>; <name><surname>Boraston</surname><given-names>A. B.</given-names></name>; <name><surname>Atherly</surname><given-names>T.</given-names></name>; <name><surname>Ziemer</surname><given-names>C. J.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Abbott</surname><given-names>D. W.</given-names></name>; <name><surname>Martens</surname><given-names>E. C.</given-names></name>; <name><surname>Gilbert</surname><given-names>H. J.</given-names></name>
<source>Nature</source>
<year>2015</year>, <volume>517</volume>, <fpage>165</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nature13995</pub-id>.<pub-id pub-id-type="pmid">25567280</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Sinnott</surname><given-names>M. L.</given-names></name>
<source>Chem. Rev.</source>
<year>1990</year>, <volume>90</volume>, <fpage>1171</fpage>&#x02013;<lpage>202</lpage><pub-id pub-id-type="doi">10.1021/cr00105a006</pub-id>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Zechel</surname><given-names>D. L.</given-names></name>; <name><surname>Withers</surname><given-names>S. G.</given-names></name>
<source>Acc. Chem. Res.</source>
<year>2000</year>, <volume>33</volume>, <fpage>11</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10639071</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Vocadlo</surname><given-names>D. J.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>
<source>Curr. Opin. Chem. Biol.</source>
<year>2008</year>, <volume>12</volume>, <fpage>539</fpage>&#x02013;<lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2008.05.010</pub-id>.<pub-id pub-id-type="pmid">18558099</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Thompson</surname><given-names>A. J.</given-names></name>; <name><surname>Williams</surname><given-names>R. J.</given-names></name>; <name><surname>Hakki</surname><given-names>Z.</given-names></name>; <name><surname>Alonzi</surname><given-names>D. S.</given-names></name>; <name><surname>Wennekes</surname><given-names>T.</given-names></name>; <name><surname>Gloster</surname><given-names>T. M.</given-names></name>; <name><surname>Songsrirote</surname><given-names>K.</given-names></name>; <name><surname>Thomas-Oates</surname><given-names>J. E.</given-names></name>; <name><surname>Wrodnigg</surname><given-names>T. M.</given-names></name>; <name><surname>Spreitz</surname><given-names>J.</given-names></name>; <name><surname>Stutz</surname><given-names>A. E.</given-names></name>; <name><surname>Butters</surname><given-names>T. D.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>
<source>Proc. Natl. Acad. Sci.
U. S. A.</source>
<year>2012</year>, <volume>109</volume>, <fpage>781</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.1111482109</pub-id>.<pub-id pub-id-type="pmid">22219371</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Gasman</surname><given-names>R. C.</given-names></name>; <name><surname>Johnson</surname><given-names>D. C.</given-names></name>
<source>J. Org. Chem.</source>
<year>1966</year>, <volume>31</volume>, <fpage>1830</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1021/jo01344a037</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Micheel</surname><given-names>F.</given-names></name>; <name><surname>Borrmann</surname><given-names>D.</given-names></name>
<source>Chem. Ber.</source>
<year>1960</year>, <volume>93</volume>, <fpage>1143</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1002/cber.19600930524</pub-id>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Kyosaka</surname><given-names>S.</given-names></name>; <name><surname>Murata</surname><given-names>S.</given-names></name>; <name><surname>Tanaka</surname><given-names>M.</given-names></name>
<source>Chem. Pharm. Bull.</source>
<year>1983</year>, <volume>31</volume>, <fpage>3902</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1248/cpb.31.3902</pub-id>.</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Speciale</surname><given-names>G.</given-names></name>; <name><surname>Farren-Dai</surname><given-names>M.</given-names></name>; <name><surname>Shidmoossavee</surname><given-names>F. S.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>; <name><surname>Bennet</surname><given-names>A. J.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2016</year>, <volume>138</volume>, <fpage>14012</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1021/jacs.6b07935</pub-id>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Speciale</surname><given-names>G.</given-names></name>; <name><surname>Thompson</surname><given-names>A. J.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>
<source>Curr. Opin. Struct. Biol.</source>
<year>2014</year>, <volume>28</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2014.06.003</pub-id>.<pub-id pub-id-type="pmid">25016573</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Pauling</surname><given-names>L.</given-names></name>
<source>Am. Sci.</source>
<year>1948</year>, <volume>36</volume>, <fpage>51</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">18920436</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Wolfenden</surname><given-names>R.</given-names></name>
<source>Acc. Chem. Res.</source>
<year>1972</year>, <volume>5</volume>, <fpage>10</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1021/ar50049a002</pub-id>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Heightman</surname><given-names>T. D.</given-names></name>; <name><surname>Vasella</surname><given-names>A. T.</given-names></name>
<source>Angew. Chem., Int. Ed.</source>
<year>1999</year>, <volume>38</volume>, <fpage>750</fpage>&#x02013;<lpage>70</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-3773(19990315)38:6&#x0003c;750::AID-ANIE750&#x0003e;3.0.CO;2-6</pub-id>.</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Gloster</surname><given-names>T. M.</given-names></name>; <name><surname>Vocadlo</surname><given-names>D. J.</given-names></name>
<source>Nat. Chem. Biol.</source>
<year>2012</year>, <volume>8</volume>, <fpage>683</fpage>&#x02013;<lpage>94</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1029</pub-id>.<pub-id pub-id-type="pmid">22810773</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Spohr</surname><given-names>U.</given-names></name>; <name><surname>Bach</surname><given-names>M.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>Can. J. Chem.</source>
<year>1993</year>, <volume>71</volume>, <fpage>1928</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="doi">10.1139/v93-240</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Alonzi</surname><given-names>D. S.</given-names></name>; <name><surname>Kukushkin</surname><given-names>N. V.</given-names></name>; <name><surname>Allman</surname><given-names>S. A.</given-names></name>; <name><surname>Hakki</surname><given-names>Z.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>; <name><surname>Pierce</surname><given-names>L.</given-names></name>; <name><surname>Dwek</surname><given-names>R. A.</given-names></name>; <name><surname>Butters</surname><given-names>T. D.</given-names></name>
<source>Cell. Mol. Life Sci.</source>
<year>2013</year>, <volume>70</volume>, <fpage>2799</fpage>&#x02013;<lpage>814</lpage><pub-id pub-id-type="doi">10.1007/s00018-013-1304-6</pub-id>.<pub-id pub-id-type="pmid">23503623</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Spohr</surname><given-names>U.</given-names></name>; <name><surname>Bach</surname><given-names>M.</given-names></name>; <name><surname>Spiro</surname><given-names>R. G.</given-names></name>
<source>Can. J. Chem.</source>
<year>1993</year>, <volume>71</volume>, <fpage>1919</fpage>&#x02013;<lpage>27</lpage><pub-id pub-id-type="doi">10.1139/v93-239</pub-id>.</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Legler</surname><given-names>G.</given-names></name>; <name><surname>Roeser</surname><given-names>K. R.</given-names></name>; <name><surname>Illig</surname><given-names>H. K.</given-names></name>
<source>Eur. J. Biochem.</source>
<year>1979</year>, <volume>101</volume>, <fpage>85</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1111/j.1432-1033.1979.tb04219.x</pub-id>.<pub-id pub-id-type="pmid">389631</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Arribas</surname><given-names>J. C.</given-names></name>; <name><surname>Herrero</surname><given-names>A. G.</given-names></name>; <name><surname>Martin-Lomas</surname><given-names>M.</given-names></name>; <name><surname>Canada</surname><given-names>F. J.</given-names></name>; <name><surname>He</surname><given-names>S.</given-names></name>; <name><surname>Withers</surname><given-names>S. G.</given-names></name>
<source>Eur. J. Biochem.</source>
<year>2000</year>, <volume>267</volume>, <fpage>6996</fpage>&#x02013;<lpage>7005</lpage><pub-id pub-id-type="doi">10.1046/j.1432-1327.2000.01784.x</pub-id>.<pub-id pub-id-type="pmid">11106409</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Hill</surname><given-names>C. H.</given-names></name>; <name><surname>Graham</surname><given-names>S. C.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>; <name><surname>Deane</surname><given-names>J. E.</given-names></name>
<source>Proc. Natl. Acad. Sci.
U. S. A.</source>
<year>2013</year>, <volume>110</volume>, <fpage>20479</fpage>&#x02013;<lpage>84</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311990110</pub-id>.<pub-id pub-id-type="pmid">24297913</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Murshudov</surname><given-names>G. N.</given-names></name>; <name><surname>Skubak</surname><given-names>P.</given-names></name>; <name><surname>Lebedev</surname><given-names>A. A.</given-names></name>; <name><surname>Pannu</surname><given-names>N. S.</given-names></name>; <name><surname>Steiner</surname><given-names>R. A.</given-names></name>; <name><surname>Nicholls</surname><given-names>R. A.</given-names></name>; <name><surname>Winn</surname><given-names>M. D.</given-names></name>; <name><surname>Long</surname><given-names>F.</given-names></name>; <name><surname>Vagin</surname><given-names>A. A.</given-names></name>
<source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<year>2011</year>, <volume>67</volume>, <fpage>355</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="doi">10.1107/S0907444911001314</pub-id>.<pub-id pub-id-type="pmid">21460454</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>McNicholas</surname><given-names>S.</given-names></name>; <name><surname>Potterton</surname><given-names>E.</given-names></name>; <name><surname>Wilson</surname><given-names>K. S.</given-names></name>; <name><surname>Noble</surname><given-names>M. E. M.</given-names></name>
<source>Acta Crystallogr.,
Sect.
D: Biol. Crystallogr.</source>
<year>2011</year>, <volume>67</volume>, <fpage>386</fpage>&#x02013;<lpage>94</lpage><pub-id pub-id-type="doi">10.1107/S0907444911007281</pub-id>.<pub-id pub-id-type="pmid">21460457</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Santana</surname><given-names>A. G.</given-names></name>; <name><surname>Vadlamani</surname><given-names>G.</given-names></name>; <name><surname>Mark</surname><given-names>B. L.</given-names></name>; <name><surname>Withers</surname><given-names>S. G.</given-names></name>
<source>Chem. Commun.</source>
<year>2016</year>, <volume>52</volume>, <fpage>7943</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1039/C6CC02520J</pub-id>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Watts</surname><given-names>A. G.</given-names></name>; <name><surname>Damager</surname><given-names>I.</given-names></name>; <name><surname>Amaya</surname><given-names>M. L.</given-names></name>; <name><surname>Buschiazzo</surname><given-names>A.</given-names></name>; <name><surname>Alzari</surname><given-names>P.</given-names></name>; <name><surname>Frasch</surname><given-names>A. C.</given-names></name>; <name><surname>Withers</surname><given-names>S. G.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2003</year>, <volume>125</volume>, <fpage>7532</fpage>&#x02013;<lpage>3</lpage><pub-id pub-id-type="doi">10.1021/ja0344967</pub-id>.<pub-id pub-id-type="pmid">12812490</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>von
Itzstein</surname><given-names>M.</given-names></name>; <name><surname>Wu</surname><given-names>W.-Y.</given-names></name>; <name><surname>Kok</surname><given-names>G. B.</given-names></name>; <name><surname>Pegg</surname><given-names>M. S.</given-names></name>; <name><surname>Dyason</surname><given-names>J. C.</given-names></name>; <name><surname>Jin</surname><given-names>B.</given-names></name>; <name><surname>Phan</surname><given-names>T. V.</given-names></name>; <name><surname>Smythe</surname><given-names>M. L.</given-names></name>; <name><surname>White</surname><given-names>H. F.</given-names></name>; <name><surname>Oliver</surname><given-names>S. W.</given-names></name>; <name><surname>Colman</surname><given-names>P. M.</given-names></name>; <name><surname>Varghese</surname><given-names>J. N.</given-names></name>; <name><surname>Ryan</surname><given-names>D. M.</given-names></name>; <name><surname>Woods</surname><given-names>J. M.</given-names></name>; <name><surname>Bethell</surname><given-names>R. C.</given-names></name>; <name><surname>Hotham</surname><given-names>V. J.</given-names></name>; <name><surname>Cameron</surname><given-names>J. M.</given-names></name>; <name><surname>Penn</surname><given-names>C. R.</given-names></name>
<source>Nature</source>
<year>1993</year>, <volume>363</volume>, <fpage>418</fpage>&#x02013;<lpage>23</lpage><pub-id pub-id-type="doi">10.1038/363418a0</pub-id>.<pub-id pub-id-type="pmid">8502295</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Shidmoossavee</surname><given-names>F. S.</given-names></name>; <name><surname>Watson</surname><given-names>J. N.</given-names></name>; <name><surname>Bennet</surname><given-names>A. J.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume>, <fpage>13254</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1021/ja405916q</pub-id>.<pub-id pub-id-type="pmid">24001125</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Liang</surname><given-names>X.</given-names></name>; <name><surname>S&#x000f8;hoel</surname><given-names>H.</given-names></name>; <name><surname>B&#x000fc;low</surname><given-names>A.</given-names></name>; <name><surname>Bols</surname><given-names>M.</given-names></name>
<source>J.
Am. Chem. Soc.</source>
<year>2001</year>, <volume>123</volume>, <fpage>5116</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1021/ja010240u</pub-id>.<pub-id pub-id-type="pmid">11457350</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Goddard-Borger</surname><given-names>E. D.</given-names></name>; <name><surname>Stick</surname><given-names>R. V.</given-names></name>
<source>Aust. J. Chem.</source>
<year>2007</year>, <volume>60</volume>, <fpage>211</fpage>&#x02013;<lpage>3</lpage><pub-id pub-id-type="doi">10.1071/CH07016</pub-id>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Mayer</surname><given-names>T. G.</given-names></name>; <name><surname>Schmidt</surname><given-names>R. R.</given-names></name>
<source>Eur. J. Org. Chem.</source>
<year>1999</year>, <volume>1999</volume>, <fpage>1153</fpage>&#x02013;<lpage>65</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-0690(199905)1999:5&#x0003c;1153::AID-EJOC1153&#x0003e;3.0.CO;2-S</pub-id>.</mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Meloncelli</surname><given-names>P. J.</given-names></name>; <name><surname>Gloster</surname><given-names>T. M.</given-names></name>; <name><surname>Money</surname><given-names>V. A.</given-names></name>; <name><surname>Tarling</surname><given-names>C. A.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Withers</surname><given-names>S. G.</given-names></name>; <name><surname>Stick</surname><given-names>R. V.</given-names></name>
<source>Aust. J. Chem.</source>
<year>2007</year>, <volume>60</volume>, <fpage>549</fpage>&#x02013;<lpage>65</lpage><pub-id pub-id-type="doi">10.1071/CH07188</pub-id>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Planas</surname><given-names>A.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>
<source>Acc. Chem. Res.</source>
<year>2012</year>, <volume>45</volume>, <fpage>308</fpage>&#x02013;<lpage>16</lpage><pub-id pub-id-type="doi">10.1021/ar2001765</pub-id>.<pub-id pub-id-type="pmid">21923088</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Williams</surname><given-names>R. J.</given-names></name>; <name><surname>Iglesias-Fernandez</surname><given-names>J.</given-names></name>; <name><surname>Stepper</surname><given-names>J.</given-names></name>; <name><surname>Jackson</surname><given-names>A.</given-names></name>; <name><surname>Thompson</surname><given-names>A. J.</given-names></name>; <name><surname>Lowe</surname><given-names>E. C.</given-names></name>; <name><surname>White</surname><given-names>J. M.</given-names></name>; <name><surname>Gilbert</surname><given-names>H. J.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>
<source>Angew. Chem., Int. Ed.</source>
<year>2014</year>, <volume>53</volume>, <fpage>1087</fpage>&#x02013;<lpage>91</lpage><pub-id pub-id-type="doi">10.1002/anie.201308334</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Tankrathok</surname><given-names>A.</given-names></name>; <name><surname>Iglesias-Fern&#x000e1;ndez</surname><given-names>J.</given-names></name>; <name><surname>Williams</surname><given-names>R. J.</given-names></name>; <name><surname>Pengthaisong</surname><given-names>S.</given-names></name>; <name><surname>Baiya</surname><given-names>S.</given-names></name>; <name><surname>Hakki</surname><given-names>Z.</given-names></name>; <name><surname>Robinson</surname><given-names>R. C.</given-names></name>; <name><surname>Hrmova</surname><given-names>M.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>; <name><surname>Williams</surname><given-names>S. J.</given-names></name>; <name><surname>Ketudat Cairns</surname><given-names>J. R.</given-names></name>
<source>ACS Catal.</source>
<year>2015</year>, <volume>5</volume>, <fpage>6041</fpage>&#x02013;<lpage>51</lpage><pub-id pub-id-type="doi">10.1021/acscatal.5b01547</pub-id>.</mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Warnke</surname><given-names>S.</given-names></name>; <name><surname>von Helden</surname><given-names>G.</given-names></name>; <name><surname>Pagel</surname><given-names>K.</given-names></name>
<source>J.
Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume>, <fpage>1177</fpage>&#x02013;<lpage>80</lpage><pub-id pub-id-type="doi">10.1021/ja308528d</pub-id>.<pub-id pub-id-type="pmid">23320566</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Winter</surname><given-names>G.</given-names></name>
<source>J. Appl. Crystallogr.</source>
<year>2010</year>, <volume>43</volume>, <fpage>186</fpage>&#x02013;<lpage>90</lpage><pub-id pub-id-type="doi">10.1107/S0021889809045701</pub-id>.</mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Kabsch</surname><given-names>W.</given-names></name>
<source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<year>2010</year>, <volume>66</volume>, <fpage>125</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id>.<pub-id pub-id-type="pmid">20124692</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Evans</surname><given-names>P. R.</given-names></name>
<source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<year>2011</year>, <volume>67</volume>, <fpage>282</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1107/S090744491003982X</pub-id>.<pub-id pub-id-type="pmid">21460446</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Evans</surname><given-names>P. R.</given-names></name>; <name><surname>Murshudov</surname><given-names>G. N.</given-names></name>
<source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<year>2013</year>, <volume>69</volume>, <fpage>1204</fpage>&#x02013;<lpage>14</lpage><pub-id pub-id-type="doi">10.1107/S0907444913000061</pub-id>.<pub-id pub-id-type="pmid">23793146</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Lohkamp</surname><given-names>B.</given-names></name>; <name><surname>Scott</surname><given-names>W. G.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name>
<source>Acta Crystallogr., Sect. D:
Biol. Crystallogr.</source>
<year>2010</year>, <volume>66</volume>, <fpage>486</fpage>&#x02013;<lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><name><surname>Tickle</surname><given-names>I.</given-names></name>
<source>Acta Crystallogr.,
Sect. D: Biol. Crystallogr.</source>
<year>2012</year>, <volume>68</volume>, <fpage>454</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="doi">10.1107/S0907444911035918</pub-id>.<pub-id pub-id-type="pmid">22505266</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Agirre</surname><given-names>J.</given-names></name>; <name><surname>Davies</surname><given-names>G.</given-names></name>; <name><surname>Wilson</surname><given-names>K.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name>
<source>Nat. Chem. Biol.</source>
<year>2015</year>, <volume>11</volume>, <fpage>303</fpage><pub-id pub-id-type="doi">10.1038/nchembio.1798</pub-id>.<pub-id pub-id-type="pmid">25885951</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Agirre</surname><given-names>J.</given-names></name>; <name><surname>Iglesias-Fernandez</surname><given-names>J.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>; <name><surname>Davies</surname><given-names>G. J.</given-names></name>; <name><surname>Wilson</surname><given-names>K. S.</given-names></name>; <name><surname>Cowtan</surname><given-names>K. D.</given-names></name>
<source>Nat. Struct. Mol.
Biol.</source>
<year>2015</year>, <volume>22</volume>, <fpage>833</fpage>&#x02013;<lpage>4</lpage><pub-id pub-id-type="doi">10.1038/nsmb.3115</pub-id>.<pub-id pub-id-type="pmid">26581513</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Schanda</surname><given-names>P.</given-names></name>; <name><surname>Kup&#x0010d;e</surname><given-names>&#x00045;&#x00305;.</given-names></name>; <name><surname>Brutscher</surname><given-names>B.</given-names></name>
<source>J. Biomol. NMR</source>
<year>2005</year>, <volume>33</volume>, <fpage>199</fpage>&#x02013;<lpage>211</lpage><pub-id pub-id-type="doi">10.1007/s10858-005-4425-x</pub-id>.<pub-id pub-id-type="pmid">16341750</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Delaglio</surname><given-names>F.</given-names></name>; <name><surname>Grzesiek</surname><given-names>S.</given-names></name>; <name><surname>Vuister</surname><given-names>G. W.</given-names></name>; <name><surname>Zhu</surname><given-names>G.</given-names></name>; <name><surname>Pfeifer</surname><given-names>J.</given-names></name>; <name><surname>Bax</surname><given-names>A.</given-names></name>
<source>J.
Biomol. NMR</source>
<year>1995</year>, <volume>6</volume>, <fpage>277</fpage>&#x02013;<lpage>93</lpage><pub-id pub-id-type="doi">10.1007/BF00197809</pub-id>.<pub-id pub-id-type="pmid">8520220</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Car</surname><given-names>R.</given-names></name>; <name><surname>Parrinello</surname><given-names>M.</given-names></name>
<source>Phys. Rev. Lett.</source>
<year>1985</year>, <volume>55</volume>, <fpage>2471</fpage>&#x02013;<lpage>4</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.55.2471</pub-id>.<pub-id pub-id-type="pmid">10032153</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Troullier</surname><given-names>N.</given-names></name>; <name><surname>Martins</surname><given-names>J. L.</given-names></name>
<source>Phys. Rev. B: Condens.
Matter Mater. Phys.</source>
<year>1991</year>, <volume>43</volume>, <fpage>1993</fpage>&#x02013;<lpage>2006</lpage><pub-id pub-id-type="doi">10.1103/PhysRevB.43.1993</pub-id>.</mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Perdew</surname><given-names>J. P.</given-names></name>; <name><surname>Burke</surname><given-names>K.</given-names></name>; <name><surname>Ernzerhof</surname><given-names>M.</given-names></name>
<source>Phys. Rev. Lett.</source>
<year>1996</year>, <volume>77</volume>, <fpage>3865</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1103/PhysRevLett.77.3865</pub-id>.<pub-id pub-id-type="pmid">10062328</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Biarnes</surname><given-names>X.</given-names></name>; <name><surname>Ardevol</surname><given-names>A.</given-names></name>; <name><surname>Planas</surname><given-names>A.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>; <name><surname>Laio</surname><given-names>A.</given-names></name>; <name><surname>Parrinello</surname><given-names>M.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2007</year>, <volume>129</volume>, <fpage>10686</fpage>&#x02013;<lpage>93</lpage><pub-id pub-id-type="doi">10.1021/ja068411o</pub-id>.<pub-id pub-id-type="pmid">17696342</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Raich</surname><given-names>L.</given-names></name>; <name><surname>Borodkin</surname><given-names>V.</given-names></name>; <name><surname>Fang</surname><given-names>W.</given-names></name>; <name><surname>Castro-Lopez</surname><given-names>J.</given-names></name>; <name><surname>van Aalten</surname><given-names>D. M.</given-names></name>; <name><surname>Hurtado-Guerrero</surname><given-names>R.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2016</year>, <volume>138</volume>, <fpage>3325</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b10092</pub-id>.<pub-id pub-id-type="pmid">26859322</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Ard&#x000e8;vol</surname><given-names>A.</given-names></name>; <name><surname>Rovira</surname><given-names>C.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2015</year>, <volume>137</volume>, <fpage>7528</fpage>&#x02013;<lpage>47</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b01156</pub-id>.<pub-id pub-id-type="pmid">25970019</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Laio</surname><given-names>A.</given-names></name>; <name><surname>Parrinello</surname><given-names>M.</given-names></name>
<source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2002</year>, <volume>99</volume>, <fpage>12562</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1073/pnas.202427399</pub-id>.<pub-id pub-id-type="pmid">12271136</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal" id="cit59"><name><surname>Tribello</surname><given-names>G. A.</given-names></name>; <name><surname>Bonomi</surname><given-names>M.</given-names></name>; <name><surname>Branduardi</surname><given-names>D.</given-names></name>; <name><surname>Camilloni</surname><given-names>C.</given-names></name>; <name><surname>Bussi</surname><given-names>G.</given-names></name>
<source>Comput.
Phys. Commun.</source>
<year>2014</year>, <volume>185</volume>, <fpage>604</fpage>&#x02013;<lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.cpc.2013.09.018</pub-id>.</mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="journal" id="cit60"><name><surname>Cremer</surname><given-names>D.</given-names></name>; <name><surname>Pople</surname><given-names>J. A.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>1975</year>, <volume>97</volume>, <fpage>1354</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1021/ja00839a011</pub-id>.</mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal" id="cit61"><name><surname>Dowd</surname><given-names>M. K.</given-names></name>; <name><surname>French</surname><given-names>A. D.</given-names></name>; <name><surname>Reilly</surname><given-names>P. J.</given-names></name>
<source>Carbohydr. Res.</source>
<year>1994</year>, <volume>264</volume>, <fpage>1</fpage>&#x02013;<lpage>19</lpage><pub-id pub-id-type="doi">10.1016/0008-6215(94)00185-5</pub-id>.</mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal" id="cit62"><name><surname>Tiwary</surname><given-names>P.</given-names></name>; <name><surname>Parrinello</surname><given-names>M.</given-names></name>
<source>J. Phys. Chem. B</source>
<year>2015</year>, <volume>119</volume>, <fpage>736</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="doi">10.1021/jp504920s</pub-id>.<pub-id pub-id-type="pmid">25046020</pub-id></mixed-citation></ref></ref-list></back></article>